The Global Liposomal Drug-delivery System Market was valued at USD 3.33 Billion in 2023 and is projected to reach USD 7.91 Billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 10.1% during the forecast period (2024–2032). This impressive growth stems from rising demand for precision medicine, technological advancements in nanotechnology, and expanding therapeutic applications across oncology, infectious diseases, and dermatology sectors.

As pharmaceutical innovation shifts toward targeted delivery mechanisms with minimized side effects, liposomal encapsulation has emerged as a transformative therapeutic platform. In this comprehensive analysis, we examine the Top 10 Companies in the Liposomal Drug-delivery System Market—the industry leaders driving advancements in drug formulation and delivery technologies.

---

🔟 1. Lipoid Kosmetik AG

Headquarters: Steinhausen, Switzerland
Key Offering: Pharmaceutical-grade phospholipids, cosmetic liposome formulations

Lipoid Kosmetik dominates the liposomal ingredients market with vertically integrated manufacturing of natural-origin phospholipids. The company supplies critical components for both advanced therapeutics and cosmetic applications.

Innovation Highlights:

• Pioneer in plant-based lipid sourcing (Non-GMO soy, sunflower)

• GMP and ISO-certified production facilities

• Custom formulation services for specialty applications

Download FREE Sample Report: Liposomal Drug-delivery System Market – View in Detailed Research Report

---

9️⃣ 2. Croda International Plc

Headquarters: Snaith, United Kingdom
Key Offering: High-purity phosphatidylcholines, drug delivery platforms

Croda’s Healthcare division provides essential lipid components and develops advanced delivery systems for pharmaceutical applications, with particular strength in oncology formulations.

Innovation Highlights:

• Industry-leading purity standards (>99%)

• Sustainable sourcing initiatives reducing environmental impact

---

8️⃣ 3. NOF Corporation

Headquarters: Tokyo, Japan
Key Offering: Functional lipids, PEGylated delivery systems

NOF Corporation stands at the forefront of synthetic lipid innovation, supplying critical components for mRNA vaccines and targeted cancer therapies.

Innovation Highlights:

• Market leader in PEGylated lipid technologies

• Patented thermostable lipid nanoparticle platforms

---

7️⃣ 4. Nikko Chemicals Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: Custom liposome development, surface-modified vesicles

Nikko Chemicals specializes in complex liposomal formulations with enhanced targeting capabilities and controlled release profiles.

Innovation Highlights:

• Proprietary active targeting technologies

• GMP manufacturing compliance for pharmaceutical applications

Read Full Report: Liposomal Drug-delivery System Market – View in Detailed Research Report

---

6️⃣ 5. Lipotec S.A.U. (Merck KGaA)

Headquarters: Barcelona, Spain
Key Offering: Cosmetic peptide delivery systems

As part of Merck KGaA, Lipotec develops advanced liposomal systems for dermatological and aesthetic medicine applications.

Innovation Highlights:

• Proprietary peptide encapsulation technologies

• Multilamellar vesicle formulations for sustained release

---

5️⃣ 6. KYOWA PHARMA CHEMICAL CO., LTD.

Headquarters: Osaka, Japan
Key Offering: Pharmaceutical excipient lipids

KYOWA specializes in high-purity lipids essential for stable injectable formulations, serving major pharmaceutical companies worldwide.

Innovation Highlights:

• Patented synthesis methods for critical lipid components

• Regulatory-compliant manufacturing facilities

---

4️⃣ 7. Creative Biostructure

Headquarters: Shirley, New York, USA
Key Offering: Custom liposome development services

This biotechnology firm provides end-to-end liposome engineering from formulation development to commercial-scale production.

Innovation Highlights:

• Specialized triggered-release system development

• GMP-compliant contract manufacturing services

Download FREE Sample Report: Liposomal Drug-delivery System Market – View in Detailed Research Report

---

3️⃣ 8. Nanohealth Biotech

Headquarters: Hyderabad, India
Key Offering: Herbal liposomal formulations

Nanohealth Biotech combines traditional Ayurvedic medicine with advanced liposomal delivery technologies for enhanced bioavailability.

Innovation Highlights:

• Bioactive-enhanced delivery platforms

• Cost-effective manufacturing processes

---

2️⃣ 9. Phenbiox Ltd.

Headquarters: Budapest, Hungary
Key Offering: Antioxidant delivery systems

Phenbiox focuses on advanced liposomal systems for dermatological applications, particularly antioxidant delivery and anti-aging formulations.

Innovation Highlights:

• Stable vitamin C encapsulation technology

• Patented skin penetration enhancement systems

---

1️⃣ 10. Kewpie Corporation

Headquarters: Tokyo, Japan
Key Offering: Nutraceutical delivery systems

Kewpie applies liposome technology to functional foods and dietary supplements, improving nutrient bioavailability and stability.

Innovation Highlights:

• Heat-stable oral delivery formulations

• Novel applications in food-grade encapsulation

---

🌍 Market Outlook: The Future of Targeted Drug Delivery

The liposomal drug delivery market is undergoing significant transformation as precision medicine advances and regulatory pathways for complex formulations mature. Key therapeutic areas—particularly oncology, vaccine development, and dermatology—are driving innovation in targeted delivery systems.

📈 Key Trends Shaping the Industry:

• Expansion into mRNA vaccine platforms post-COVID-19

• Increased adoption in combination therapies and personalized medicine

• Advancements in active targeting and triggered-release technologies

• Growing demand for biosimilar liposomal formulations

Read Full Report: Liposomal Drug-delivery System Market – View in Detailed Research Report

The companies profiled above represent the innovation leaders in liposomal technology—advancing therapeutic efficacy while improving patient outcomes through targeted drug delivery approaches that minimize systemic side effects.